US 6906050
Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis
expired A61KA61K47/546A61K49/085
Quick answer
US patent 6906050 (Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis) held by Miravant Pharmaceuticals, Inc. expires Mon Jun 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Miravant Pharmaceuticals, Inc.
- Grant date
- Tue Jun 14 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K47/546, A61K49/085, A61K49/10, A61K49/106